Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Several studies have provided ample evidence of a clinically significant interobserver variation of the histological diagnosis of glioma. This interobserver variation has an effect on both the typing and grading of glial tumors. Since treatment decisions are based on histological diagnosis and grading, this affects patient care: erroneous classification and grading may result in both over- and undertreatment. In particular, the radiotherapy dosage and the use of chemotherapy are affected by tumor grade and lineage. It also affects the conduct and interpretation of clinical trials on glioma, in particular of studies into grade II and grade III gliomas. Although trials with central pathology review prior to inclusion will result in a more homogeneous patient population, the interpretation and external validity of such trials are still affected by this, and the question whether results of such trials can be generalized to patients diagnosed and treated elsewhere remains to be answered. Although molecular classification may help in typing and grading tumors, as of today this is still in its infancy and unlikely to completely replace histological classification. Routine pathology review in everyday clinical practice should be considered. More objective histological criteria for the grade and lineage of gliomas are urgently needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Histologic diagnosis and grading of gliomas have been limited by considerable intra- and interobserver variability (42).”
From Predicting cancer outcomes from histology and genomics using convolutional networks (2018) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the grading criteria in the current classification schema for oligodendrogliomas continues to predominantly rely upon histopathologic examination; the differentiating criterion between grade 2 and grade 3 oligodendrogliomas are the presence of conspicuous microvascular proliferation and/or 6 mitoses per 10 high-power field [3,4,5,6,7,8,9,10,11].”
From BPC 157 Therapy of Myotendinous Junction Injury in Rats (2025) · cites this paper as [9]
Experimental — accuracy not yet measuredIn the citing paper
“Importantly, these data further facilitate consensus ratings on radiology images (e.g., MRI) of expert radiologists to alleviate inconsistencies that often arise due to subjective impressions and inter- and intra-observer variability [229].”
From AI in Medical Imaging Informatics: Current Challenges and Future Directions (2020) · cites this paper as [229]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544 · cited 1×
“This issue is on the question of external validation or generalizability of the results of a trial, an often ignored element of clinical trials [26].”
BackgroundCairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ino, Y., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.19.1473 · Cited by 1,610
Feinstein, A. R., Sosin, D. M., & Wells, C. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506203122504 · Cited by 1,544
An analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
Nutt, C. L., Mani, D. R., Betensky, R. A., Tamayo, P., Cairncross, J. G., Ladd, C., Pohl, U., Hartmann, C. J., McLaughlin, M. E., Batchelor, T. T., et al. (2003) · PubMed · Cited by 1,058
van den Bent, M., Afra, D., de Witte, O., Hassel, M. B., Schraub, S., Hoang-Xuan, K., Malmström, P.-O., Collette, L., Piérart, M., Mirimanoff, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67070-5 · Cited by 1,035
Wick, W., Hartmann, C., Engel, C., Stoffels, M., Felsberg, J., Stockhammer, F., Sabel, M. C., Koeppen, S., Ketter, R., Meyermann, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6497 · Cited by 809
Smith, J. S., Perry, A., Borell, T. J., Lee, H. K., O’Fallon, J., Hosek, S. M., Kimmel, D., Yates, A., Burger, P. C., Scheithauer, B. W., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.636 · Cited by 804
van den Bent, M. J., Carpentier, A. F., Brandes, A. A., Sanson, M., Taphoorn, M. J. B., Bernsen, H. J. J. A., Frenay, M., Tijssen, C. C., Grisold, W., Sipos, L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6078 · Cited by 748
Research works printed but not linked: 1
- Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK (1997) Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79:1381–1391 · doi:10.1002/(sici)1097-0142(19970401)79:7<1381::aid-cncr16>3.0.co;2-w
Cited by
Items 501–600 of 640
Using high-throughput sequencing to study the progression of cancer
Grifford, M. (2014) · eScholarship (California Digital Library)
Développement d'interfaces micro/nano pour la capture d'espèces biologiques in vivo
Dreyfus, M. (2015) · theses.fr (ABES) · doi:10.70675/6c75ea6fz6095z4a7cz9a05z300e2d9b7ed6
Diagnosis and prognosis of brain tumors in clinical trials
Gorlia, T. (2013) · RePub (Erasmus University Rotterdam)
An overview of current and future treatment options for adults anaplastic oligodendroglial tumors
Ducray, F., Dehais, C., Delattre, J., & POLA Network (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.928617
Los «tiempos» —timing— en Neurooncología
Parera, I. C., Báez, A., Roffo, A. G., Kuchkaryan, V., Barros, J. M., Halfón, M. J., Tamborini, N. M., Larrarte, G. A., Blumenkrantz, Y., de Robles, P. A., et al. (2014) · Neurología Argentina · doi:10.1016/j.neuarg.2014.05.005
STEM CELL SIGNATURES IN GLIOMA
He, X. (2012) · Figshare
Impacts of Biology in Therapeutic Management of Malignant Gliomas
Epari, S., & Jalali, R. (2012) · Journal of the Indian Institute of Science
2-Hydroxyglutarate as a biomarker in glioma patients
Lombardi, G. (2014) · Padua@research (University of Padova)
Comprehensive Genomic Analysis of Infiltrative Gliomas Based on Molecular Profile
Starke, R. M., Connolly, E. S., & Komotar, R. J. (2016) · Neurosurgery · doi:10.1227/01.neu.0000481986.14010.df
The enigma of ependymal tumors: a journey in their genomic and transcriptomic landscapes
Olsen, T. K. (2016) · NVA (Nasjonalt vitenarkiv)
Sala, Q., Métellus, P., Chinot, O. L., Boyer, L., Bialecki, E., Dufour, H., & Guedj, É. (2016) · Médecine Nucléaire · doi:10.1016/j.mednuc.2016.03.139
Tumor-Specific Approach: Oligodendroglioma (IDH1 Mutated, 1p/19q Deleted)
Leyrer, C. M., Murphy, E. S., & Ahluwalia, M. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-49864-5_17
Evaluation of the diagnostic and prognostic value of IDH1 and Progranulin in patients with Gliomas
Ribeiro, M. A. L. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Bacci, A., Marucci, G., Budai, C., Sacchetti, F., & Agati, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-44174-0_19
Pathogenesis of Diffuse Low-Grade Gliomas
Pendleton, C. A., Motomura, K., & Natsume, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-55466-2_6
A GLO10 score for the prediction of prognosis in high grade gliomas
Chen, F., Peng, P., Zhou, Y., Yang, Z., Zhang, H.-Q., Ao, X.-S., Zhou, D.-Q., & Xiang, C. (2017) · Oncotarget · doi:10.18632/oncotarget.20195
Resektionsausmaß und Prognose bei Gliomen: „Viel hilft viel“ oder „Alles oder nichts“?
Gousias, K., & Simon, M. (2017) · Springer eBooks · doi:10.1007/978-3-662-48694-8_29
Routman, D. M., & Brown, P. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-42878-9_5
Student, S., Płuciennik, A., Jakubczak, M., & Fujarewicz, K. (2018) · Lecture notes in computer science · doi:10.1007/978-3-319-99344-7_29
Einfluss der Resektion bei molekular definierten niedriggradigen Gliomen
Ille, S., & Krieg, S. M. (2018) · Info Onkologie · doi:10.1007/s15004-018-6216-z
Adam, S. (2018) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.23522
Tumor Genetics and Their Outcomes on Surgery and Survival
Ehresman, J., & Bettegowda, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811783-5.00010-0
Sabedot, T. S. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-17102018-142049
Prognostication and Surgical Management of Diffuse Gliomas in the Era of Molecular Diagnostics
Wijnenga, M. M. J. (2019) · EUR Research Repository (Erasmus University Rotterdam)
Etiological and Epidemiological Aspects
Jacobs, D. I., Amirian, E. S., Claus, E. B., Jenkins, R. B., Bondy, M. L., & Wrensch, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-04152-6_2
Richards, T. J., Anderson, J. E., Reed, M., Poelstra, R. J., Satter, M. R., & Kardan, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813158-9.00014-1
Surgical management of 1p/19q co-deleted oligodendrogliomas WHO grade II and III
Thon, N., Kreth, F.-W., & Tonn, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813158-9.00018-9
Sierra, R. R. (2019) · Communities in ADDI (Universidad del Pais Vasco)
MOLECULAR CONSEQUENCES OF HIGH TAZ EXPRESSION IN GLIOMAS
Ravikumar, V. (2019) · Digital Commons-TMC (Texas Medical Center)
Koh, L. (2019) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/138683
A radical shift in the diagnostic approach to diffuse gliomas
Panth, R. (2020) · Journal of Pathology of Nepal · doi:10.3126/jpn.v10i1.28947
Longitudinal Brain Tumor Tracking, Tumor Grading, and Patient Survival Prediction Using MRI
Pei, L. (2020) · ODU Digital Commons (Old Dominion University) · doi:10.25777/ee4a-vd66
Diffuse low-grade glioma and anaplastic glioma in the elderly
Lindqvist, A. (2019) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Imaging and Resection of Glioblastomain light of molecular markers
Incekara, F. (2021) · RePub (Erasmus University Rotterdam)
Molecular Stratification of Adult and Pediatric High Grade Gliomas
Yang, Y., Dai, H., & Lopez, G. Y. (2021) · Molecular pathology library · doi:10.1007/978-3-030-69170-7_8
Pathology, Molecular Biology and Classification of Gliomas
Purkait, S. (2021) · Springer eBooks · doi:10.1007/978-981-16-2659-3_3
Arık, D., Özen, A., Özkara, E., Yılmaz, E., Canaz, F., & Yıldırım, G. D. (2021) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_183_21
Au delà des frontières du glioblastome : caractérisation de la zone péritumorale des glioblastomes
Lemée, J.-M. (2015) · theses.fr (ABES) · doi:10.70675/9704d5a4z6fcaz467az9bdfz3192c096306b
Fatterpekar, G. M., & Knopp, E. (2020) · IDKD Springer series · doi:10.1007/978-3-030-38490-6_4
Gorlia, T., & Gorlia, T. (1951) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1951.tb08185.x
WHO Glioma Classification Update and Genomics: What Radiologists Need to Know
Bai, J., Varghese, J., & Jain, R. (2020) · doi:10.26226/morressier.5e5e709500701ceba4a26ab8
Internò, V., Triggiano, G., Santis, P. D., Stucci, L. S., Tucci, M., & Porta, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.866623
Expression and prognosis of GNG5 in lower-grade glioma using public database
Tan, X., Zhou, H., Hou, L., Li, H., Liu, J., Li, Y., & Xue, X. (2022) · All Life · doi:10.1080/26895293.2022.2131636
Prisciandaro, J. I., Zoberi, J. E., Cohen, G. N., Kim, Y., Johnson, P. B., Paulson, E. S., Song, W. Y., Hwang, K., Erickson, B. E., Beriwal, S., et al. (2022) · Medical Physics · doi:10.1002/mp.15991
Mair, M. J., Leibetseder, A., Heller, G., Puhr, R., Tomasich, E., Goldberger, S., Hatziioannou, T., Wöhrer, A., Widhalm, G., Dieckmann, K. U., et al. (2023) · doi:10.1158/1078-0432.c.6532964.v1
Adult diffuse gliomas: What the neuroradiologist needs to know
Sukumar, R., Ko, A., Dueck, N. P., & Patel, S. H. (2023) · The Neuroradiology Journal · doi:10.1177/19714009231173107
Margo, C. E., & Mancera, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95788-5.00036-4
From the morphological to the integrated diagnosis of diffuse gliomas – a retrospective study
Amini, D. A. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10033
Fatterpekar, G. M., & Sundgren, P. C. (2024) · IDKD Springer series · doi:10.1007/978-3-031-50675-8_4
Du, N., Shu, W., Li, K., Deng, Y., Xu, X., Yao, Y., Tang, F., Mao, R., Lin, G., Li, S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22611400
Progressi nel trattamento dei pazienti con glioblastoma
Pïcca, A., Santonocito, O. S., & Stefano, A. L. D. (2024) · EMC - Neurologia · doi:10.1016/s1634-7072(24)49605-0
Routman, D. M., & Brown, P. D. (2024) · Springer eBooks · doi:10.1007/978-3-031-67878-3_5
Yang, L., Xie, X., Zhang, J., Chen, L., Bu, L., Wu, S., Deng, W., Yao, Y., Zhang, X., & Chen, H. (2025) · World Neurosurgery · doi:10.1016/j.wneu.2024.123624
Tumor genomics and clinical methylation
Hersh, D. S., Bulsara, K., Becker, K. G., Wu, Q., & Bulsara, K. R. (2025) · Neurological Research · doi:10.1080/01616412.2025.2486521
Mishra, P., Mohapatro, M., Gouda, K. P., Munda, F. C., & Mohanty, L. (2025) · Cureus · doi:10.7759/cureus.84522
Sun, S., Lai, L., Wu, M., Zhuang, C., Hu, Y., Chen, B., Zheng, X., Chen, Y., Mao, J., Guan, J., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00048
Moradi, E., Vuorinen, J., Hoikka, T., Hartewig, A., Helin, L., Rodriguez-Martinez, A., Pekkarinen, M., Vulli, M., Lehtipuro, S., Ampuja, S., et al. (2025) · medRxiv · doi:10.1101/2025.10.07.25337348
Mandhare, T. A., Kashid, P., Shinde, D., Khuspe, P. R., & Vyavahare, R. (2025) · IP Journal of diagnostic pathology and oncology/IP journal of diagnostic pathology and oncology/Journal of diagnostic pathology and oncology · doi:10.18231/j.jdpo.13188.1760597279
Yang, Q., Liu, G., Wang, T., Xu, Z., Yan, J., Fang, R., Luo, Y., Yu, H., Tan, Y. Q., Zhang, H., et al. (2025) · BMC Neurology · doi:10.1186/s12883-025-04420-0
Brain Tumor Detection and Classification Using ShuffleNet : A Lightweight Deep Learning Approach
M.E., M. K. N., Bhavanika, P., Mani, M. S. R. M., & Asha, A. A. (2025) · International Journal of Scientific Research in Computer Science Engineering and Information Technology · doi:10.32628/cseit251117141
Lu, Y., Du, N., Fang, X., Shu, W., Liu, W., Xu, X., Ye, Y., Xiao, L., Mao, R., Li, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26740451
Cornelli, L., Paemel, R. V., Ferro dos Santos, M. R., Roelandt, S., Willems, L., Vandersteene, J., Baert, E. J., Mus, L. M., Roy, N. V., Wilde, B. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26744267
Cornelli, L., Paemel, R. V., Ferro dos Santos, M. R., Roelandt, S., Willems, L., Vandersteene, J., Baert, E. J., Mus, L. M., Roy, N. V., Wilde, B. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26744291
KI-gestützte MR-Klassifizierung von Zellen und zellulärer Differenzierung
Fey, P. (2023) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-34516
Wang, W., Tugaoen, J. D. C., Fadda, P., Toland, A. E., Ma, Q., Elder, J. B., Giglio, P., & Otero, J. J. (2024) · Figshare · doi:10.6084/m9.figshare.26649276
Cornelli, L., Paemel, R. V., Ferro dos Santos, M. R., Roelandt, S., Willems, L., Vandersteene, J., Baert, E. J., Mus, L. M., Roy, N. V., Wilde, B. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26744294
Cornelli, L., Paemel, R. V., Ferro dos Santos, M. R., Roelandt, S., Willems, L., Vandersteene, J., Baert, E. J., Mus, L. M., Roy, N. V., Wilde, B. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26744276
Lu, Y., Du, N., Fang, X., Shu, W., Liu, W., Xu, X., Ye, Y., Xiao, L., 毛仁玲, Li, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26740457
Schepke, E., Löfgren, M., Pietsch, T., Kling, T., Nordborg, C., Bontell, T. O., Holm, S., Öberg, A., Nyman, P. O., Eliasson‐Hofvander, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26573845
Cornelli, L., Paemel, R. V., Ferro dos Santos, M. R., Roelandt, S., Willems, L., Vandersteene, J., Baert, E. J., Mus, L. M., Roy, N. V., Wilde, B. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26744285
Schepke, E., Löfgren, M., Pietsch, T., Kling, T., Nordborg, C., Bontell, T. O., Holm, S., Öberg, A., Nyman, P. O., Eliasson‐Hofvander, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26573851
Schepke, E., Löfgren, M., Pietsch, T., Kling, T., Nordborg, C., Bontell, T. O., Holm, S., Öberg, A., Nyman, P. O., Eliasson‐Hofvander, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26573854
Cornelli, L., Paemel, R. V., Ferro dos Santos, M. R., Roelandt, S., Willems, L., Vandersteene, J., Baert, E. J., Mus, L. M., Roy, N. V., Wilde, B. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26744279
Cornelli, L., Paemel, R. V., Ferro dos Santos, M. R., Roelandt, S., Willems, L., Vandersteene, J., Baert, E. J., Mus, L. M., Roy, N. V., De Wilde, B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26744273
Lu, Y., Du, N., Fang, X., Shu, W., Liu, W., Xu, X., Ye, Y., Xiao, L., 毛仁玲, Li, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26740460
Luber, C. A. (2023) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.53801
Lu, Y., Du, N., Fang, X., Shu, W., Liu, W., Xu, X., Ye, Y., Xiao, L., Mao, R., Li, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26129767
Schepke, E., Löfgren, M., Pietsch, T., Kling, T., Nordborg, C., Bontell, T. O., Holm, S., Öberg, A., Nyman, P. O., Eliasson‐Hofvander, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26573848
Lu, Y., Du, N., Fang, X., Shu, W., Liu, W., Xu, X., Ye, Y., Xiao, L., 毛仁玲, Li, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26740454
Lu, Y., Du, N., Fang, X., Shu, W., Liu, W., Xu, X., Ye, Y., Xiao, L., 毛仁玲, Li, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26129806
Perfiles de expresión de microRNAs y de alteraciones genéticas en tumores de origen glial
Ramos, I. C. (2013) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Cellular vulnerabilities of glioblastoma
Merisaari, J. (2021) · UTUPub (University of Turku)
Epigenetic modulators of signalling pathways in glioma development
Matjašič, A. (2017) · Repository of the University of Ljubljana (University of Ljubljana)
Bierlein, J. G., Schlegel, J., & München, T. U. (2024)
Human Glioblastomas: Histopathology, Tumor Growth, and MGMT Status
Mikkelsen, V. E. (2021) · NORA - Norwegian Open Research Archives
Rincón Carreño, C., & Martínez Suárez, E. A. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Identification of disease-causing variants in genes in adults with suspicion of hereditary FSGS
Herr, P.-M., Höfele, J., & München, T. U. (2024)
Investigación de las mutaciones de los genes de IDH1 y 2 en los gliomas de bajo grado
Etxaniz, O., & de Medicina, U. A. D. B. D. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
de Albuquerque, L. A., & Almeida, J. P. (2025) · Springer eBooks · doi:10.1007/978-3-031-95119-0_11
Frankle, S. (2025) · Open University of Cape Town (University of Cape Town)
Non-invasive Serum Biomarkers of Brain Tumors
Ghorbani, A. (2023) · TSpace (University of Toronto)
Development of an Anatomical Proteomic Atlas of Glioblastoma
Lam, K. H. B. (2022) · TSpace (University of Toronto)
Virtanen, P. (2024) · Tampere University Institutional Repository (Tampere University)
Irimescu, I. N., Tarbă, N., MIHAILESCU, M., PETRESCU, G. E. D., PASOV, D., Pleava, A. M., & Calin, V. L. (2026) · Romanian Journal of Physics · doi:10.59277/romjphys.2026.71.702
Etude des réponses induites par l’erlotinib dans des cellules de lignées de glioblastome
Eimer, S. (2011) · theses.fr (ABES) · doi:10.70675/48cf26bbz6b1cz4672za2d5zc83a7ce5752a
Caractérisation génomique et génétique des gliomes diffus de bas grade de l’adulte
Alentorn, A. (2014) · theses.fr (ABES) · doi:10.70675/4c970efaz0a91z4c6fza653zb307c6f64ae7
Metadata
- Authors
- van den Bent, M. J.
- Venue
- Acta Neuropathologica
- Published
- 2010-07-20
- Volume
- 120
- Issue
- 3
- Pages
- 297-304
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC2910894
- OpenAlex
- W2112567075
- Cited by
- 577
- References
- 35
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 70 · 2023: 43 · 2022: 43 · 2021: 47 · 2020: 48 · 2019: 52 · 2018: 33 · 2017: 46 · 2016: 44 · 2015: 33 · 2014: 16 · 2013: 16 · 2012: 20
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Reliability and Agreement in Measurement
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- glioma, interobserver variability, histopathological diagnosis, tumor grading, tumor classification, central pathology review, clinical trial interpretation, generalizability, molecular classification, chemotherapy
- MeSH terms
- Brain Neoplasms, Clinical Trials as Topic, Glioma, Humans, Observer Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.